ID

6281

Descripción

GOG-0262: Cycle Dose Drug Form (D2R) Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Palabras clave

  1. 18/12/14 18/12/14 - Martin Dugas
  2. 22/8/15 22/8/15 - Martin Dugas
Subido en

18 de diciembre de 2014

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GOG-0262: Cycle Dose Drug Form (D2R) - 2917656v1.0

No Instruction available.

  1. StudyEvent: SE.0000
    1. No Instruction available.
Header Module
Descripción

Header Module

Date form originally completed (m d y)
Descripción

FormOriginalCompleteDate

Tipo de datos

date

Date form amended (m d y)
Descripción

FormAmendedCompleteDate

Tipo de datos

date

Person amending form, last name
Descripción

ResponsiblePersonReportingChangeLastName

Tipo de datos

text

Patient Initials (First, Middle, Last)
Descripción

PatientInitialsName

Tipo de datos

text

Patient Study ID
Descripción

PatientGynecologicOncologyGroupIdentifierNumber

Tipo de datos

text

Person Completing Form, Last Name
Descripción

ResponsiblePersonLastName

Tipo de datos

text

Treatment Cycle And Modification
Descripción

Treatment Cycle And Modification

Current Cycle Number
Descripción

TreatmentCurrentCourseNumber

Tipo de datos

double

Cycle Delayed?
Descripción

TreatmentDelayedCycleInd-3

Tipo de datos

text

Number of days treatment cycle was delayed
Descripción

TreatmentDelayDayCount

Tipo de datos

double

Cycle delayed reason
Descripción

TreatmentDelayedCycleReason

Tipo de datos

text

Cycle start date (Day 1 m d y)
Descripción

TreatmentCourseBeginDate

Tipo de datos

date

Agent name (Drug)
Descripción

AgentName

Tipo de datos

text

Agent Dose level (e.g. mg/m^2)
Descripción

AgentDoseLevelValue

Tipo de datos

text

Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
Descripción

DoseModificationInd

Tipo de datos

text

Total dose of agents/drugs for this cycle
Descripción

AgentCourseTotalDose

Tipo de datos

double

Units (eg. mg, kg)
Descripción

AgentDoseUOM

Tipo de datos

text

Patient weight (kg)
Descripción

PatientWeightMeasurement

Tipo de datos

double

Unidades de medida
  • Kg
Kg
Body Surface Area (m^2)
Descripción

PersonBodySurfaceAreaValue

Tipo de datos

double

Unidades de medida
  • m2
m2
Performance status (Zubrod)
Descripción

PerformanceStatusAssessmentEasternCooperativeOncologyGroupScale

Tipo de datos

text

Pretreatment Hematology And Chemistry Values
Descripción

Pretreatment Hematology And Chemistry Values

Assessment Date (m d y)
Descripción

LesionAssessmentDate

Tipo de datos

date

Hemoglobin
Descripción

LaboratoryProcedureHemoglobinResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • g/dL
g/dL
Peripheral Hematocrit Count (1000/L)
Descripción

LaboratoryProcedureErythrocyteResultCount

Tipo de datos

double

Peripheral WBC Count (mm3)
Descripción

LaboratoryProcedureLeukocyteResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • 1000/uL
1000/uL
Peripheral Granulocytes Count (mm3)
Descripción

LaboratoryProcedureGranulocyteResultCount

Tipo de datos

double

Unidades de medida
  • 1000/uL
1000/uL
Peripheral Platelet Count (mm3)
Descripción

LaboratoryProcedurePlateletResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • 1000/uL
1000/uL
PT (sec)
Descripción

LaboratoryProcedureProthrombinTimeResultValue

Tipo de datos

double

Unidades de medida
  • seconds
seconds
PTT (sec) (sec)
Descripción

LaboratoryProcedurePartialThromboplastinTimeResultValue

Tipo de datos

double

BUN (mg/dl)
Descripción

LaboratoryProcedureBloodUreaNitrogenResultUnspecifiedValue

Tipo de datos

double

Creatinine (mg/dl)
Descripción

LaboratoryProcedureCreatinineResultSpecifiedValue

Tipo de datos

double

Unidades de medida
  • mg/dL
mg/dL
Creatinine Clearance (ml/min)
Descripción

LaboratoryProcedureCreatinineClearanceOutcomeValue

Tipo de datos

double

SGOT
Descripción

LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultUnspecifiedValue

Tipo de datos

double

Bilirubin
Descripción

LaboratoryProcedureTotalBilirubinResultValue

Tipo de datos

double

Unidades de medida
  • mg/dL
mg/dL
Alkaline Phosphatase
Descripción

LaboratoryProcedureAlkalinePhosphataseResultValue

Tipo de datos

double

Result of CA125 (IU/ml)
Descripción

LaboratoryProcedureCA-125AntigenTumorMarkerResultValue

Tipo de datos

double

International Normalization Ratio (INR)
Descripción

LaboratoryProcedureInternationalNormalizationRatioResultValue

Tipo de datos

double

Other, specify test
Descripción

LaboratoryProcedureSecondOptionalPerformedSpecify

Tipo de datos

text

Other specify value
Descripción

LaboratoryProcedurePerformedValue

Tipo de datos

double

Comments
Descripción

Comments

COMMENTS
Descripción

ResearchCommentsText

Tipo de datos

text

Similar models

No Instruction available.

  1. StudyEvent: SE.0000
    1. No Instruction available.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Header Module
FormOriginalCompleteDate
Item
Date form originally completed (m d y)
date
FormAmendedCompleteDate
Item
Date form amended (m d y)
date
ResponsiblePersonReportingChangeLastName
Item
Person amending form, last name
text
PatientInitialsName
Item
Patient Initials (First, Middle, Last)
text
PatientGynecologicOncologyGroupIdentifierNumber
Item
Patient Study ID
text
ResponsiblePersonLastName
Item
Person Completing Form, Last Name
text
Item Group
Treatment Cycle And Modification
TreatmentCurrentCourseNumber
Item
Current Cycle Number
double
Item
Cycle Delayed?
text
Code List
Cycle Delayed?
CL Item
No (No)
CL Item
Yes (Yes)
TreatmentDelayDayCount
Item
Number of days treatment cycle was delayed
double
Item
Cycle delayed reason
text
Code List
Cycle delayed reason
CL Item
Non Protocol Illness (Non protocol illness)
CL Item
Patient Refusal (Patient refusal)
CL Item
Personal Reasons (Personal reasons)
CL Item
Protocol Related Ae (Protocol related AE)
CL Item
Scheduling (Scheduling)
TreatmentCourseBeginDate
Item
Cycle start date (Day 1 m d y)
date
AgentName
Item
Agent name (Drug)
text
AgentDoseLevelValue
Item
Agent Dose level (e.g. mg/m^2)
text
Item
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
text
Code List
Were there any dose modifications or additions/omissions to protocol treatment (1=Yes, planned; 2 =Yes, unplanned; 3=No)
CL Item
Yes, Planned (i.e., The Treatment Was Changed According To Protocol Guidelines) (Yes, planned)
CL Item
Yes, Unplanned (i.e., The Treatment Change Was Not Part Of Protocol Guidelines) (Yes, unplanned)
CL Item
No (No)
AgentCourseTotalDose
Item
Total dose of agents/drugs for this cycle
double
AgentDoseUOM
Item
Units (eg. mg, kg)
text
PatientWeightMeasurement
Item
Patient weight (kg)
double
PersonBodySurfaceAreaValue
Item
Body Surface Area (m^2)
double
Code List
Performance status (Zubrod)
CL Item
Fully Active, Able To Carry On All Pre-disease Performance Without Restriction. (0)
CL Item
Restricted In Physically Strenuous Activity But Ambulatory And Able To Carry Out Work Of A Light Or Sedentary Nature, E.g., Light Housework, Office Work. (1)
CL Item
Ambulatory And Capable Of All Selfcare But Unable To Carry Out Any Work Activities. Up And About More Than 50% Of Waking Hours. (2)
CL Item
Capable Of Only Limited Selfcare, Confined To Bed Or Chair More Than 50% Of Waking Hours. (3)
CL Item
Completely Disabled. Cannot Carry On Any Selfcare. Totally Confined To Bed Or Chair. (4)
Item Group
Pretreatment Hematology And Chemistry Values
LesionAssessmentDate
Item
Assessment Date (m d y)
date
LaboratoryProcedureHemoglobinResultSpecifiedValue
Item
Hemoglobin
double
LaboratoryProcedureErythrocyteResultCount
Item
Peripheral Hematocrit Count (1000/L)
double
LaboratoryProcedureLeukocyteResultSpecifiedValue
Item
Peripheral WBC Count (mm3)
double
LaboratoryProcedureGranulocyteResultCount
Item
Peripheral Granulocytes Count (mm3)
double
LaboratoryProcedurePlateletResultSpecifiedValue
Item
Peripheral Platelet Count (mm3)
double
LaboratoryProcedureProthrombinTimeResultValue
Item
PT (sec)
double
LaboratoryProcedurePartialThromboplastinTimeResultValue
Item
PTT (sec) (sec)
double
LaboratoryProcedureBloodUreaNitrogenResultUnspecifiedValue
Item
BUN (mg/dl)
double
LaboratoryProcedureCreatinineResultSpecifiedValue
Item
Creatinine (mg/dl)
double
LaboratoryProcedureCreatinineClearanceOutcomeValue
Item
Creatinine Clearance (ml/min)
double
LaboratoryProcedureSerumGlutamicOxaloaceticTransferaseResultUnspecifiedValue
Item
SGOT
double
LaboratoryProcedureTotalBilirubinResultValue
Item
Bilirubin
double
LaboratoryProcedureAlkalinePhosphataseResultValue
Item
Alkaline Phosphatase
double
LaboratoryProcedureCA-125AntigenTumorMarkerResultValue
Item
Result of CA125 (IU/ml)
double
LaboratoryProcedureInternationalNormalizationRatioResultValue
Item
International Normalization Ratio (INR)
double
LaboratoryProcedureSecondOptionalPerformedSpecify
Item
Other, specify test
text
LaboratoryProcedurePerformedValue
Item
Other specify value
double
Item Group
Comments
ResearchCommentsText
Item
COMMENTS
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial